Medical equipment industry
Edwards Lifesciences Corporation, a leading manufacturer of hemodynamic-monitoring technologies, has previewed its new minimally invasive hemodynamic monitoring device, the Edwards FloTrac sensor, at the Society of Critical Care Medicine's (SCCM) 34th Critical Care Congress. The device is designed to provide clinicians with a less invasive alternative to traditional
Medical equipment industry
Cardiac arrest patients undergoing treatment with the ZOLL AutoPulse Noninvasive Cardiac Support Pump in out-of-hospital settings showed significant improvements in short-term survival rates. The results of two studies conducted in Richmond, Virginia and San Francisco, California, were presented at the 2005 Annual Meeting of the National Association of Emergency Medical
Medical equipment industry
STERIS Corporation, a leading infection prevention and decontamination technologies company, reported a decline in revenue for the third quarter of fiscal 2005 compared to the same period in fiscal 2004. The decrease in revenue was attributed to a lower level of demand for capital equipment in Europe and weakness in
Medical equipment industry
The Food and Drug Administration (FDA) has approved a new drug called Prialt, a man-made version of snail venom, for patients who have exhausted all other options to combat chronic pain. Developed by scientists at Elan Corp., Prialt will be administered through implantable drug-delivery pumps made by Medtronic Inc. and
Medical equipment industry
Market Pulse has featured Lifestream Technologies, Inc. (OTCBB:LFTC) to the investment community, highlighting the company's potential as a significant player in the healthcare industry. Lifestream's CEO will testify at the FDA hearing on cholesterol-lowering drugs, which could be positive news for investors. Other notable stocks,
Medical equipment industry
Market Pulse, a leading investor relations firm, has introduced Lifestream Technologies, Inc. (OTCBB: LFTC) to the investment community, highlighting the company's potential to become a significant player in the healthcare industry. Lifestream Technologies is poised to benefit from its CEO's scheduled testimony at the FDA hearing
Medical equipment industry
Medtronic, Inc. has released a statement in response to the U.S. District Court's decisions in Delaware regarding patent litigation with Guidant Corporation and Boston Scientific Corporation. The court's rulings addressed various patent infringements and validity claims, with both Guidant and Boston Scientific facing partial dismissals
Medical equipment industry
Angiotech Pharmaceuticals, Inc., a leading developer of innovative medical technologies, has announced that Boston Scientific Corporation has elected to become the exclusive worldwide licensee to Angiotech's coronary drug-eluting stent technology. This agreement will have a significant impact on Angiotech's revenue streams, with the company set to
Medical equipment industry
The 90th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) featured InSightec's ExAblate 2000 Magnetic Resonance-guided Focused Ultrasound (MRgFUS) system, which offers a non-invasive treatment for uterine fibroids. The system combines MRI with high-intensity focused ultrasound to ablate tissue without incisions. On October
Medical equipment industry
The first patient has been enrolled in the MAVErIC III Clinical Trial, a study evaluating the safety and efficacy of a new system of devices to treat blockages in the carotid arteries, which can lead to ischemic strokes. The trial, led by Robert Molnar, MD, at McLaren Regional Medical Center
Medical equipment industry
Medtronic's Diabetes business unit and Novo Nordisk have announced a partnership to develop prefilled cartridges for use with Paradigm external insulin pumps. The collaboration aims to simplify pump therapy for patients with type 1 and type 2 diabetes, who currently need to manually transfer insulin from a vial
Medical equipment industry
In a monumental day of corporate restructurings, four companies involved in over $62 billion of acquisitions dominated premarket trading on Thursday. The mergers of Guidant Corp. and Johnson and Johnson, Valued at $23.9 billion, and Symantec Corp. and Veritas Software Corp., valued at $13.5 billion, sent shockwaves through
